Christian Kollmannsberger, MD

Articles by Christian Kollmannsberger, MD

UFT/Calcium Folinate Plus Weekly Paclitaxel for Solid Tumors

ByCarsten Bokemeyer, MD,Jörg Thomas Hartmann, MD,Christian Kollmannsberger, MD,Frank Mayer, MD,Lothar Kanz, MD

July 1st 1999

Since cancer is incurable in many patients, palliation of symptoms and quality-of-life issues are important aspects of therapy. Uracil and tegafur (UFT) plus calcium folinate are the components of the oral agent known

Latest Updated Articles

UFT/Calcium Folinate Plus Weekly Paclitaxel for Solid Tumors
Published: July 1st 1999 | Updated:

Christian Kollmannsberger, MD

Articles by Christian Kollmannsberger, MD

UFT/Calcium Folinate Plus Weekly Paclitaxel for Solid Tumors

Latest Updated Articles

Trending on CancerNetwork

AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights

FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars

BL-B01D1 Shows Preliminary Efficacy, Favorable Safety in Urothelial Cancer

Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs

Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis